Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ranolazine (ranexa) (1 trial)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Metabolic Syndrome (Phase 4)
Myocardial Ischemia (Phase 4)
Syndrome (Phase 4)
Trials (1 total)
Trial APIs (1 total)